Authors:
Morimoto, H
Shimadzu, H
Kushiyama, E
Kawanishi, H
Hosaka, T
Kawase, Y
Yasuda, K
Kikkawa, K
Yamauchi-Kohno, R
Yamada, K
Citation: H. Morimoto et al., Potent and selective ET-A antagonists. 1. Syntheses and structure-activityrelationships of N-(6-(2-(aryloxy)ethoxy)-4-pyrimidinyl)sulfonamide derivatives, J MED CHEM, 44(21), 2001, pp. 3355-3368
Authors:
Morimoto, H
Ohashi, N
Shimadzu, H
Kushiyama, E
Kawanishi, H
Hosaka, T
Kawase, Y
Yasuda, K
Kikkawa, K
Yamauchi-Kohno, R
Yamada, K
Citation: H. Morimoto et al., Potent and selective ET-A antagonists. 2. Discovery and evaluation of potent and water soluble N-(6-(2-(aryloxy)ethoxy)-4-pyrimidinyl)sulfonamide derivatives, J MED CHEM, 44(21), 2001, pp. 3369-3377
Authors:
Inada, T
Fujiwara, H
Hasegawa, K
Araki, M
Yamauchi-Kohno, R
Yabana, H
Fujiwara, T
Tanaka, M
Sasayama, S
Citation: T. Inada et al., Upregulated expression of cardiac endothelin-1 participates in myocardial cell growth in Bio14.6 Syrian cardiomyopathic hamsters, J AM COL C, 33(2), 1999, pp. 565-571
Authors:
Kikkawa, K
Saito, A
Iwasaki, H
Ban, Y
Yasoshima, A
Yamauchi-Kohno, R
Hoshino, T
Murata, S
Citation: K. Kikkawa et al., Prevention of cerebral vasospasm by a novel endothelin receptor antagonist, TA-0201, J CARDIO PH, 34(5), 1999, pp. 666-673
Authors:
Kikkawa, K
Hoshino, T
Yamauchi-Kohno, R
Murata, S
Citation: K. Kikkawa et al., Characteristics of heterogeneity in the expression of vasoconstriction in response to N-G-monomethyl-L-arginine in isolated canine arteries, EUR J PHARM, 379(2-3), 1999, pp. 167-173
Authors:
Itoh, H
Yokochi, A
Yamauchi-Kohno, R
Maruyama, K
Citation: H. Itoh et al., Effects of the endothelin ETA receptor antagonist, TA-0201, on pulmonary arteries isolated from hypoxic rats, EUR J PHARM, 376(3), 1999, pp. 233-238
Authors:
Yamauchi-Kohno, R
Miyauchi, T
Hoshino, T
Kobayashi, T
Aihara, H
Sakai, S
Yabana, H
Goto, K
Sugishita, Y
Murata, S
Citation: R. Yamauchi-kohno et al., Role of endothelin in deterioration of heart failure due to cardiomyopathyin hamsters - Increase in endothelin-1 production in the heart and beneficial effect of endothelin-A receptor antagonist on survival and cardiac function, CIRCULATION, 99(16), 1999, pp. 2171-2176